{"title":"Can you measure the quality of this life? Interview by Lauren M. Walker.","authors":"P C Langley, M A Testa","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The value and application of quality of life measurements in evaluating health care remain difficult to determine and controversial. Can quality of life be measured in a meaningful way? Can improved quality of life be connected to productivity improvements or other cost factors? We talked to two of the liveliest (and most opinionated) researchers in the field of quality of life outcomes assessment. Paul C. Langley, PhD, is currently employed by 3M Pharmaceuticals as U.S. and international manager of health economics. Before that, he was director of the Program in Pharmaceutical Economics and Health Systems Research at the University of Colorado. Marcia A. Testa, MPH, PhD, is a senior lecturer in biostatistics at the Harvard School of Public Health and a consultant with Phase V Technologies Inc., a firm that assists health care organizations in outcomes trials. Here are their thoughts on the state of the art.</p>","PeriodicalId":79567,"journal":{"name":"Business and health","volume":"18 9","pages":"42-4, 47-8"},"PeriodicalIF":0.0000,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Business and health","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The value and application of quality of life measurements in evaluating health care remain difficult to determine and controversial. Can quality of life be measured in a meaningful way? Can improved quality of life be connected to productivity improvements or other cost factors? We talked to two of the liveliest (and most opinionated) researchers in the field of quality of life outcomes assessment. Paul C. Langley, PhD, is currently employed by 3M Pharmaceuticals as U.S. and international manager of health economics. Before that, he was director of the Program in Pharmaceutical Economics and Health Systems Research at the University of Colorado. Marcia A. Testa, MPH, PhD, is a senior lecturer in biostatistics at the Harvard School of Public Health and a consultant with Phase V Technologies Inc., a firm that assists health care organizations in outcomes trials. Here are their thoughts on the state of the art.
生活质量测量在评价卫生保健方面的价值和应用仍然难以确定和有争议。生活质量能以一种有意义的方式衡量吗?生活质量的提高是否与生产力的提高或其他成本因素有关?我们采访了生活质量结果评估领域最活跃(也是最固执己见)的两位研究人员。Paul C. Langley，博士，目前受雇于3M制药公司，担任美国和国际卫生经济学经理。在此之前，他是科罗拉多大学药物经济学和卫生系统研究项目的主任。Marcia a . Testa，公共卫生硕士，博士，是哈佛大学公共卫生学院生物统计学高级讲师，也是Phase V Technologies Inc.(一家协助医疗保健组织进行结果试验的公司)的顾问。以下是他们对技术现状的看法。
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
